- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on Hedgehog Inhibitor
Total 534 results
-
Peking Union Medical College HospitalActive, not recruitingNon Small Cell Lung Cancer | Neoadjuvant Therapy | Immune Checkpoint InhibitorChina
-
Karen-Lise Garm SpindlerCompletedColorectal Cancer Metastatic | KRAS Gene Mutation | Circulating Tumor DNA | BRAF Gene Mutation | NRAS Gene Mutation | Epidermal Growth Factor Receptor InhibitorDenmark
-
Central Hospital, Nancy, FranceCompletedAdenocarcinoma of Lung Stage IV | Adenocarcinoma of Lung, Response to Tyrosine Kinase Inhibitor in, SomaticFrance
-
Tang-Du HospitalRecruitingChemotherapy | Esophageal Squamous Cell Carcinoma | PD-1 Inhibitor | NeoadjuventChina
-
The University of Hong KongRecruitingRecurrent Glioblastoma | Recurrent Glioma | Poly ADP Ribose Polymerase (PARP) Inhibitor | PTEN Gene Inactivation | IDH MutationHong Kong
-
Shanghai Chest HospitalNot yet recruitingCardiac Event | Immune Checkpoint Inhibitor | Adverse Reactions | Non-Small Cell Lung Cancer Patients
-
Institute of Oncology LjubljanaUniversity of Ljubljana; Military Medical Academy, Belgrade, SerbiaRecruitingMetastatic Melanoma | Immune Checkpoints Inhibitors | Gastrointestinal Microbiome (Bacterial and Viral) | Exosomal mRNA Expression of PD-L1 and IFNγSlovenia
-
Shenzhen Second People's HospitalRecruitingChronic Myeloid Leukemia, Chronic Phase | Olverembatinib | Tyrosine Kinase InhibitorsChina
-
Ain Shams UniversityCompletedNephrotic Syndrome | Sodium-Glucose Transporter 2 InhibitorsEgypt
-
Skane University HospitalCompleted
-
Fondazione IRCCS Ca' Granda, Ospedale Maggiore...UnknownHemophilia A With InhibitorsUnited States, Germany, France, Italy, Romania, Spain
-
Guangxi Medical UniversityWuzhou Red Cross Hospital; Wuhan Union Hospital, China; Yunnan Cancer Hospital; Hainan People's Hospital and other collaboratorsNot yet recruitingNasopharyngeal Carcinoma | Neoadjuvant Therapy | PD-1 Inhibitor
-
National Taiwan University HospitalRecruitingPharmacokinetics | Therapeutic Drug Monitoring | Tyrosine Kinase InhibitorTaiwan
-
Hunan Cancer HospitalRecruitingChemotherapy Effect | NK/T-cell Lymphoma of Nasal Cavity | Immune Checkpoint Inhibitor | Epigenetic DisorderChina
-
Hangzhou Cancer HospitalUnknownNon-small Cell Lung Cancer | Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor (EGFR-TKI)China
-
Novo Nordisk A/SRecruitingHaemophilia A With Inhibitors | Haemophilia ATaiwan, Canada, Spain, Netherlands, Korea, Republic of, India, United States, United Kingdom, China, Portugal, Lithuania, Turkey, South Africa, Ireland, Italy, France, Japan, Belgium, Malaysia, Poland, Austria, Bulgaria, Denmark, Germany and more
-
Sun Yat-sen UniversityNot yet recruitingCervical Cancer | Chemotherapy Effect | Neoadjuvant Therapy | Programmed Cell Death 1 Receptor / Antagonists & Inhibitors
-
Novo Nordisk A/SActive, not recruitingHaemophilia A With Inhibitors | Haemophilia ASpain, Korea, Republic of, Canada, United Kingdom, United States, Germany, South Africa, Italy, Austria, Belgium, France, Japan
-
OPKO Health, Inc.CompletedHemophilia A or B With InhibitorsIsrael
-
Thomas Jefferson UniversityWyeth is now a wholly owned subsidiary of PfizerWithdrawnNeurotoxicity | Renal Toxicity | Side Effects of Calcineurin Inhibitors | Hepatic Fibrosis on Biopsy | Post Transplant DiabetesUnited States
-
Hospital Universitario La PazUnknownSevere Haemophilia A With InhibitorsSpain
-
Novo Nordisk A/SRecruitingHaemophilia A With Inhibitors | Haemophilia AUnited States, Korea, Republic of, France, Spain, Romania, Canada, Taiwan, China, Lithuania, Netherlands, India, South Africa, Russian Federation, Austria, Belgium, Czechia, Denmark, Germany, Ireland, Italy, Japan, Latvia, Malaysia, M... and more
-
Sun Yat-sen UniversityRecruitingMuscle-Invasive Bladder Carcinoma | Radiotherapy | Programmed Cell Death Protein 1 InhibitorChina
-
Xiaoxiang ChenNot yet recruitingOvarian Cancer | HRD | PARP InhibitorChina
-
Chinese PLA General HospitalUnknownAtherosclerosis Type 2 Diabetes Mellitus Dipeptidyl Peptidase-4 Inhibitor GLP-1
-
Fudan UniversityUnknownNeoplasms | Immune System Diseases | Lymphoma, B-Cell | Lymphoma, Large B-Cell, Diffuse | Lymphoproliferative Disorders | Lymphatic Diseases | Immunoproliferative Disorders | Lymphoma, Non-Hodgkin | Gemcitabine | Cisplatin | Dexamethasone | Rituximab | Cyclophosphamide | Chidamide | Neoplasm by Histology | HDAC InhibitorChina
-
Chulalongkorn UniversityRecruitingComparison of Outcomes Between Low Dose Emicizumab and Factor VIII in Clinically Severe Hemophilia AJoint Bleed | Severe Hemophilia A Without InhibitorThailand
-
Tianjin Medical University Cancer Institute and...RecruitingCarcinoma, Non-Small-Cell Lung | EGF-R Positive Non-Small Cell Lung Cancer | Bevacizumab | Tyrosine Kinase InhibitorChina
-
University of Castilla-La ManchaMinisterio de Economía y Competitividad, Spain; Servicio de Salud de Castilla-La...RecruitingExercise Training | Fasting, Intermittent | Metabolic Syndrome, Protection Against | Metformin | Angiotensin Hypertension | Statins | Angiotensin-Converting-Enzyme InhibitorSpain
-
Daiichi Sankyo, Inc.PlexxikonTerminatedV600-mutated BRAF Unresectable Melanoma | V600-mutated BRAF Metastatic Melanoma | Stage III or Stage IV Metastatic Melanoma That Has Not Been Previously Treated With a Selective BRAF InhibitorUnited States, Germany, France
-
University Hospital Inselspital, BerneRigshospitalet, Copenhagen, Denmark (Prof. Moller, Dr. Krag)CompletedCritical Illness | Acute Kidney Injury | Renal Replacement Therapy | End-stage Renal Disease | Proton Pump InhibitorDenmark, Switzerland
-
Peking Union Medical College HospitalRecruitingLung Cancer | Chemotherapy | Antibody | COVID-19 Recurrent | Vaccination | Immune Checkpoint InhibitorChina
-
Peking Union Medical College HospitalNot yet recruitingNon Small Cell Lung Cancer | Immune Checkpoint Inhibitor | EGFR Exon 21 MutationChina
-
Ajou University School of MedicineDong-A ST Co., Ltd.Not yet recruitingCerebral Infarction | Dipeptidyl-Peptidase IV Inhibitors | Infarction, Brain
-
Fudan UniversityNot yet recruitingthe Efficacy and Safety of PD-1 Inhibitors With or Without Radiotherapy in Patients With Advanced MelanomaChina
-
Bioverativ, a Sanofi companySwedish Orphan BiovitrumCompletedHemophilia A With InhibitorsUnited States, Spain, Canada, Belgium, France, Bulgaria, Italy, United Kingdom, Japan, Germany
-
Instituto Nacional de RehabilitacionEnrolling by invitationEnzyme Inhibitors | Hydroxychloroquine | Antimalarials | Antirheumatic AgentsMexico
-
Children's Hospital Los AngelesWithdrawnHemophilia A With Inhibitors
-
University Hospital, Basel, SwitzerlandCompletedMyocardial Ischemia | Thrombosis | Coronary Artery Bypass Graft Triple Vessel | Antithrombotic Drugs [Platelet-aggregation Inhibitors] Causing Adverse Effects in Therapeutic UseSwitzerland
-
New York Presbyterian HospitalManchester University NHS Foundation TrustTerminated
-
Assiut UniversityNot yet recruitingChronic Heart Disease | SGLT2 Inhibitiors Remodeling Effect
-
Nanyang Technological UniversityNational Research Foundation, Singapore; Ministry of National Development,... and other collaboratorsRecruitingMental Fatigue | Heart Rate Variability | Working Memory | Cognitive Fatigue | Behavioral Performance | Positive and Negative Affect | Inhibition, Psychological | Perceived RestorationSingapore
-
Novo Nordisk A/SRecruitingHaemophilia A and B With and Without InhibitorsUnited States, Spain, Italy, Estonia, Thailand, Canada, India, Malaysia, United Kingdom, Turkey, South Africa, Lebanon, Bulgaria, France, Greece, Japan, Lithuania, Norway, Poland, Romania, Russian Federation, Sweden, Algeria, North Macedonia and more
-
General and Teaching Hospital CeljeCompletedDiabetes Mellitus, Type 1 | Biomarkers | Endothelial Dysfunction | Arterial Stiffness | FMD | Incretins | Endothelial Progenitor Cells | SGLT 2 Inhibitors | Glucose Excursions | FPFSlovenia
-
Chongqing University Cancer HospitalNot yet recruitingPARP Inhibitor for Esophageal Squamous Cell Carcinoma
-
CSL BehringCompletedCystic FibrosisBulgaria, Hungary, Poland, United Kingdom
-
Novartis PharmaceuticalsCompletedTumor Pathway Activations Inhibited by DovitinibUnited States
-
Nanyang Technological UniversityNational Research Foundation, Singapore; Ministry of National Development,... and other collaboratorsRecruitingMental Fatigue | Inhibition | Heart Rate Variability | Working Memory | Cognitive Fatigue | Behavioral Performance | Skin Conductance | Positive and Negative Affect | Perceived RestorationSingapore
-
Flinders UniversityFlinders Medical Centre; Lyell McEwin HospitalRecruitingMyocardial Injury | Myocarditis | Cardiotoxicity | Immune Checkpoint InhibitorsAustralia
-
Novo Nordisk A/SRecruitingHaemophilia A With or Without InhibitorsIndia, China, Korea, Republic of, Canada, Spain, Netherlands, South Africa, United States, Israel, Poland, United Kingdom, Italy, Japan, Lithuania, Portugal, Switzerland, Taiwan